Defining a pharmacophore for the design of MDR modulators

Determining a pharmacophore for identifying (e.g. by screening) and designing molecules which possess multi-drug resistance (MDR) modulatory activity. The pharmacophore represents a 3-dimensional aggregate array of positions in space of the field points of a series of molecules having the same, or s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: PHILIP ANTHONY ASHWORTH
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PHILIP ANTHONY ASHWORTH
description Determining a pharmacophore for identifying (e.g. by screening) and designing molecules which possess multi-drug resistance (MDR) modulatory activity. The pharmacophore represents a 3-dimensional aggregate array of positions in space of the field points of a series of molecules having the same, or similar, MDR modulatory activity, and describes regions of positive or negative maxima in the local electrostatic field associated with a molecule, and van der Waals surfaces. A number of lowest energy conformations for each molecule are determined and selected, and interconformational comparisons between conformers of pairs of molecules are carried out and ranked in order of Coulombic overlay energy. A conformational mapping joins pairs of conformers in the top three ranked comparisons (fig. 3), and an optimum cyclic path is determined. This joins all the molecules, with their conformations selected such that the total Coulombic overlay energy over the path is minimised (fig. 4). The field points of these "active" conformations on the cyclic point are combined using an aggregate average method, to generate the pharmacophore.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GB2317030A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GB2317030A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GB2317030A3</originalsourceid><addsrcrecordid>eNrjZLB0SU3LzMvMS1dIVCjISCzKTUzOL8jIL0pVSMsvUijJSFVISS3OTM9TyE9T8HUJUsjNTynNSSzJLyrmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXx7k5GxobmBsYGjsaEVQAARgYtHg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Defining a pharmacophore for the design of MDR modulators</title><source>esp@cenet</source><creator>PHILIP ANTHONY ASHWORTH</creator><creatorcontrib>PHILIP ANTHONY ASHWORTH</creatorcontrib><description>Determining a pharmacophore for identifying (e.g. by screening) and designing molecules which possess multi-drug resistance (MDR) modulatory activity. The pharmacophore represents a 3-dimensional aggregate array of positions in space of the field points of a series of molecules having the same, or similar, MDR modulatory activity, and describes regions of positive or negative maxima in the local electrostatic field associated with a molecule, and van der Waals surfaces. A number of lowest energy conformations for each molecule are determined and selected, and interconformational comparisons between conformers of pairs of molecules are carried out and ranked in order of Coulombic overlay energy. A conformational mapping joins pairs of conformers in the top three ranked comparisons (fig. 3), and an optimum cyclic path is determined. This joins all the molecules, with their conformations selected such that the total Coulombic overlay energy over the path is minimised (fig. 4). The field points of these "active" conformations on the cyclic point are combined using an aggregate average method, to generate the pharmacophore.</description><edition>6</edition><language>eng</language><subject>CALCULATING ; CHEMISTRY ; COMPUTING ; COUNTING ; ELECTRIC DIGITAL DATA PROCESSING ; INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; TESTING</subject><creationdate>1998</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19980311&amp;DB=EPODOC&amp;CC=GB&amp;NR=2317030A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19980311&amp;DB=EPODOC&amp;CC=GB&amp;NR=2317030A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PHILIP ANTHONY ASHWORTH</creatorcontrib><title>Defining a pharmacophore for the design of MDR modulators</title><description>Determining a pharmacophore for identifying (e.g. by screening) and designing molecules which possess multi-drug resistance (MDR) modulatory activity. The pharmacophore represents a 3-dimensional aggregate array of positions in space of the field points of a series of molecules having the same, or similar, MDR modulatory activity, and describes regions of positive or negative maxima in the local electrostatic field associated with a molecule, and van der Waals surfaces. A number of lowest energy conformations for each molecule are determined and selected, and interconformational comparisons between conformers of pairs of molecules are carried out and ranked in order of Coulombic overlay energy. A conformational mapping joins pairs of conformers in the top three ranked comparisons (fig. 3), and an optimum cyclic path is determined. This joins all the molecules, with their conformations selected such that the total Coulombic overlay energy over the path is minimised (fig. 4). The field points of these "active" conformations on the cyclic point are combined using an aggregate average method, to generate the pharmacophore.</description><subject>CALCULATING</subject><subject>CHEMISTRY</subject><subject>COMPUTING</subject><subject>COUNTING</subject><subject>ELECTRIC DIGITAL DATA PROCESSING</subject><subject>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1998</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB0SU3LzMvMS1dIVCjISCzKTUzOL8jIL0pVSMsvUijJSFVISS3OTM9TyE9T8HUJUsjNTynNSSzJLyrmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXx7k5GxobmBsYGjsaEVQAARgYtHg</recordid><startdate>19980311</startdate><enddate>19980311</enddate><creator>PHILIP ANTHONY ASHWORTH</creator><scope>EVB</scope></search><sort><creationdate>19980311</creationdate><title>Defining a pharmacophore for the design of MDR modulators</title><author>PHILIP ANTHONY ASHWORTH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GB2317030A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1998</creationdate><topic>CALCULATING</topic><topic>CHEMISTRY</topic><topic>COMPUTING</topic><topic>COUNTING</topic><topic>ELECTRIC DIGITAL DATA PROCESSING</topic><topic>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>PHILIP ANTHONY ASHWORTH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PHILIP ANTHONY ASHWORTH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Defining a pharmacophore for the design of MDR modulators</title><date>1998-03-11</date><risdate>1998</risdate><abstract>Determining a pharmacophore for identifying (e.g. by screening) and designing molecules which possess multi-drug resistance (MDR) modulatory activity. The pharmacophore represents a 3-dimensional aggregate array of positions in space of the field points of a series of molecules having the same, or similar, MDR modulatory activity, and describes regions of positive or negative maxima in the local electrostatic field associated with a molecule, and van der Waals surfaces. A number of lowest energy conformations for each molecule are determined and selected, and interconformational comparisons between conformers of pairs of molecules are carried out and ranked in order of Coulombic overlay energy. A conformational mapping joins pairs of conformers in the top three ranked comparisons (fig. 3), and an optimum cyclic path is determined. This joins all the molecules, with their conformations selected such that the total Coulombic overlay energy over the path is minimised (fig. 4). The field points of these "active" conformations on the cyclic point are combined using an aggregate average method, to generate the pharmacophore.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_GB2317030A
source esp@cenet
subjects CALCULATING
CHEMISTRY
COMPUTING
COUNTING
ELECTRIC DIGITAL DATA PROCESSING
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
title Defining a pharmacophore for the design of MDR modulators
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T21%3A53%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PHILIP%20ANTHONY%20ASHWORTH&rft.date=1998-03-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGB2317030A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true